PPIRE10549

Target Protein Information
Protein_Name None
Protein_Sequence LVSIRVGGQIKEALLDTGADDTVLEEVNLPGKWKPKMIGGIGGFIKVRQYDQIPIEICGKKAIGTVLVGPTPINIIGRNMLTQLGCTLNFPISPIETVPVKLKPGMDGPK
Organism_Source Human immunodeficiency virus type 1
Functional_Classification aspartic proteases
Cellular_Localization Cytoplasm
Gene_Names pol
UniProt_ID M1KCG9
Protein-Protein Interaction Networks
Peptide Basic Information
Peptide_Name compound 22
Peptide_Sequence XSIAE
Peptide_Length 5
Peptide_SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O
Chemical_Modification X1=5-hydroxy-4-oxahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecane
Cyclization_Method None
Linear/Cyclic Linear
N-terminal_Modification Free
C-terminal_Modification Free
Amino_Acid_Distribution
Peptide Physicochemical
Molecular_Weight 475.50
Aliphatic_Index 98.00000
Aromaticity 0.00000
Average_Rotatable_Bonds 3.00000
Charge_at_pH_7 -1.00024
Isoelectric_Point 3.84998
Number_of_Hydrogen_Bond_Acceptors 8
Number_of_Hydrogen_Bond_Donors 8
Topological_Polar_Surface_Area 237.25000
X_logP_energy -3.10800
Interaction Information
Affinity IC50=60 uM
Affinity_Assay Enzyme Inhibition Kinetics
PDB_ID None
Type Inhibitor
Structure
Reference Information
Document_Type Research Articles
Title Pentacycloundecane derived hydroxy acid peptides: a new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors.
Release_Year 2012
PMID 21982718
DOI 10.1016/j.bioorg.2011.08.002